David Huberman works closely with Israeli and domestic clients, representing issuers and underwriters on capital raising transactions, including private and public offerings. He regularly represents Israeli companies in their initial public offerings on U.S. stock exchanges and advises on ongoing compliance with U.S. securities laws. David’s clients include pharmaceutical and technology companies currently traded, or on their way to the Nasdaq.
- Public and private offerings
- Mergers and acquisitions
- Pharma, medical device, digital health and other life science
- Israeli practice